Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03670160 · ClinicalTrials.gov registry record · Phase 2
Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome
A Phase 2 study, sponsored by University of Tennessee Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT03670160 is a Phase 2 study that has completed, run by University of Tennessee Medical Center. The registered enrollment target is 25 participants.
The verdict
NCT03670160, a Phase 2 study, has completed, sponsored by University of Tennessee Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to compare clonidine versus phenobarbital as adjunctive therapy in those infants who have failed monotherapy with morphine sulfate for neonatal abstinence syndrome (NAS).
Interventions
- DRUG Clonidine
- DRUG Phenobarbital
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2020-05-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03670160
The ClinicalTrials.gov registry entry for NCT03670160 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee Medical Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clonidine is the first listed.
NCT03670160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03670160 about?
NCT03670160 is a clinical study titled "Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome". The purpose of this study is to compare clonidine versus phenobarbital as adjunctive therapy in those infants who have failed monotherapy with morphine sulfate for neonatal abstinence syndrome (NAS).
What is the current status of trial NCT03670160?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2018-10-01. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT03670160?
The interventions under investigation include: Clonidine (DRUG), Phenobarbital (DRUG).
Who is sponsoring clinical trial NCT03670160?
This trial is sponsored by University of Tennessee Medical Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.